The effect of mesenchymal stromal cells of various origins on morphology of hippocampal CA1 area of rats with acute cerebral ischemia

Home/2022, Vol. 10, No. 2/The effect of mesenchymal stromal cells of various origins on morphology of hippocampal CA1 area of rats with acute cerebral ischemia

Cell and Organ Transplantology. 2022; 10(2):in press.
DOI: 10.22494/cot.v10i2.144

The effect of mesenchymal stromal cells of various origins on morphology of hippocampal CA1 area of rats with acute cerebral ischemia

Konovalov S.1, Moroz V.1, Deryabina O.2, Klymenko P.2,3, Tochylovsky A.4, Kordium V.2,5

  • 1National Pirogov Memorial Medical University, Vinnytsya, Ukraine
  • 2Institute of Genetic and Regenerative Medicine, M. D. Strazhesko National Scientific Center of Cardiology, Clinical and Regenerative Medicine, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine Kyiv, Ukraine
  • 3D. F. Chebotarev State Institute of Gerontology, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
  • 4BioTexCom LLC, Kyiv, Ukraine
  • 5Institute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine, Kyiv, Ukraine

Abstract

Every year, about 150,000 strokes occur in Ukraine, and more than 100,000 people die from the consequences of stroke and other circulatory disorders in the brain. So far, promising experimental data on the treatment of neurological dysfunction using mesenchymal stromal cells (MSCs) have been obtained.
Purpose: to characterize the impact of MSCs of various origins, lysate of Wharton’s jelly-derived MSCs and citicoline on the dynamics of destructive changes in the hippocampal CA1 area of rats with model of acute cerebral ischemia according to morphometric data.
Materials and methods. An experiment was performed using 4-month-old male Wistar rats, which were subjected to transient bilateral 20-minute ischemia-reperfusion (IR) of the internal carotid arteries. After modeling, the animals were injected intravenously with Wharton’s jelly-derived MSCs, human and rat adipose-derived MSCs at a dose 106 cells/animal. Other groups were intravenously injected with rat fetal fibroblasts at a dose of 106 cells/animal and lysate from Wharton’s umbilical cord MSCs at a dose of 0.2 mL/animal. Control animals were injected with 0.2 mL of saline. The last group of rats received a single dose of the reference drug citicoline at a dose of 250 mg/kg. On the 7th and 14th day, the total number of neuron nuclei per 1 mm2 brain section was counted in the hippocampal CA1 area, and the ratio of the number of intact neuron nuclei and nuclei with changes (karyorrhexis and karyopyknosis) was determined.
Results. The transplantation of MSCs, lysate of Wharton’s jelly-derived MSCs, or citicoline contributed to a greater value of the number of nuclei in the hippocampal CA1 area, and the number of nuclei that did not undergo pathological changes also increased. The transplantation of Wharton’s jelly-derived MSCs had the most positive effect. The number of neuron nuclei per 1 mm2 in the hippocampal CA1 area in this group of animals approached the number of nuclei in the group of sham-operated animals. At the same time, the number of nuclei that did not undergo pathological changes significantly exceeded the number of nuclei with signs of destruction.
Conclusion. A significant increase in the number of neurons without signs of pathological changes was observed in all experimental groups of rats during the modeling of ischemic brain injury after the administration of various types of studied mesenchymal stromal cells, lysate or citicoline. The most positive result in the hippocampal CA1 area was achieved after the administration of Wharton’s jelly-derived MSCs.

Key words: ischemic stroke; mesenchymal stromal cells; hippocampal CA1 area; cell transplantation

 

1. Available from: https://www.world-stroke.org/world-stroke-day-campaign/why-stroke-matters/learn-about-stroke
2. Available from: https://phc.org.ua/news/29-zhovtnya-vsesvitniy-den-borotbi-z-insultom
3. Available from: https://www.kmu.gov.ua/news/u-2020-roci-likuvannya-gostrogo-mozkovogo-insultu-ye-prioritetom-v-programi-medichnih-garantij
4. Available from: https://www.kmu.gov.ua/news/stacionarne-likuvannya-gostrogo-mozkovogo-insultu-shcho-zminitsya-u-programi-medichnih-garantij-2021
5. Kahle KT, Simard JM, Staley KJ, Nahed BV, Jones PS, Sun D. Molecular mechanisms of ischemic cerebral edema: role of electroneutral ion transport. Physiology (Bethesda). 2009; 24:257-65. 2. Available from: https://doi.org/10.1152/physiol.00015.2009
https://doi.org/10.1152/physiol.00015.2009
PMid:19675357
6. Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018; 378:708-718. Available from: https://doi.org/10.1056/NEJMoa1713973
https://doi.org/10.1056/NEJMoa1713973
PMid:29364767 PMCid:PMC6590673
7. Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018; 378:11-21. Available from: https://doi.org/10.1056/NEJMoa1706442
https://doi.org/10.1056/NEJMoa1706442
PMid:29129157
8. Cheng T, Yang B, Li D, et al. Wharton’s Jelly transplantation improves neurologic function in a rat model of traumatic brain injury. Cell Mol Neurobiol. 2015; 35:641-9. Available from: https://doi.org/10.1007/s10571-015-0159-9
https://doi.org/10.1007/s10571-015-0159-9
PMid:25638565 PMCid:PMC4481175
9. Donders R, Bogie JFJ, Ravanidis S, et al. Human Wharton’s Jelly-derived stem cells display a distinct immunomodulatory and proregenerative transcriptional signature compapared to bone marrow-derived stem cells. Stem Cells Dev. 2018; 27:65-84. Available from: https://doi.org/10.1089/scd.2017.0029
https://doi.org/10.1089/scd.2017.0029
PMid:29267140
10. He JQ, Sussman ES, Steinberg GK. Revisiting Stem Cell-Based Clinical Trials for Ischemic Stroke. Front Aging Neurosci. 2020; 12:575990. Available from: https://doi.org/10.3389/fnagi.2020.575990
https://doi.org/10.3389/fnagi.2020.575990
PMid:33381020 PMCid:PMC7767918
11. Wu KJ, Yu SJ, Chiang CW, et al. Neuroprotective action of human wharton’s jelly-derived mesenchymal stromal cell transplants in a rodent model of stroke. Cell Transplant. 2018; 27: 1603-1612. Available from: https://doi.org/10.1177/0963689718802754
https://doi.org/10.1177/0963689718802754
PMid:30284460 PMCid:PMC6299196
12. Hsieh JY, Wang HW, Chang SJ, Liao KH, Lee IH, Lin WS, et al. Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis. PLoS One. 2013; 8(8):e72604. Available from: https://doi.org/10.1371/journal.pone.0072604
https://doi.org/10.1371/journal.pone.0072604
PMid:23991127 PMCid:PMC3749979
13. Pedachenko EG, Moroz VV, Yatsyk VA, Malyar UI, Liubich LD, Egorova DM. Autologous cell using for the restoration of functional defects in patients with ischemic cerebrovascular accident. Ukrainian Interventional Neuroradiology and Surgery. 2020; 33(3):83-93. [In Ukrainian]. Available from: https://doi.org/10.26683/2304-9359-2020-3(33)-83-93
https://doi.org/10.26683/2304-9359-2020-3(33)-83-93
14. Toyoshima A, Yasuhara T, Kameda M, Morimoto J, Takeuchi H, Wang F. Intra-arterial transplantation of allogeneic mesenchymal stem cells mounts neuroprotective effects in a transient ischemic stroke model in rats: analyses of therapeutic time window and its mechanisms. PLoS One 10:e0127302. Available from: https://doi.org/10.1371/journal.pone.0127302
https://doi.org/10.1371/journal.pone.0127302
PMid:26075717 PMCid:PMC4468176
15. Moisan A, Favre I, Rome C, De Fraipont F, Grillon E, Coquery N. Intravenous injection of clinical grade human MSCs after experimental stroke: functional benefit and microvascular effect. Cell Transplant. 25, 2157-2171. Available from: https://doi.org/10.3727/096368916X691132
https://doi.org/10.3727/096368916X691132
PMid:26924704
16. Konovalov S, Moroz V, Konovalova N, Deryabina O, Shuvalova N, Toporova O, et al. The effect of mesenchymal stroma cells of various origins on mortality and neurologic deficit in acute cerebral ischemia-reperfusion in rats. Cell Organ Transpl. 2021; 9(2):104-108. Available from: https://doi.org/10.22494/cot.v9i2.132
https://doi.org/10.22494/cot.v9i2.132
17. Khodakovsky AA, Marinich LI, Bagauri OV. Features of the formation of post-reperfusion damage to neurons – a characteristic of the “ischemia-reperfusion” model. New directions and prospects for the development of modern cerebroprotective therapy of ischemic stroke. Postgraduate doctor. 2013; 3(58):69-76. [In Russian]
18. Secades JJ, Gareri P. Citicoline: pharmacological and clinical review, 2022 update. Rev Neurol. 2022 Nov 30;75(s05):S1-S89. Available from: https://doi.org/10.33588/rn.75s05.2022311
19. Diederich K, Frauenknecht K, Minnerup J, et al. Citicoline enhances neuroregenerative processes after experimental stroke in rats [published correction appears in Stroke. 2012; 43(11):e169]. Stroke. 2012; 43(7):1931-1940. Available from: https://doi.org/10.1161/strokeaha.112.654806
https://doi.org/10.1161/STROKEAHA.112.654806
PMid:22581817
20. Bustamante A, Giralt D, Garcia-Bonilla L, et al. Citicoline in pre-clinical animal models of stroke: a meta-analysis shows the optimal neuroprotective profile and the missing steps for jumping into a stroke clinical trial. Journal of neurochemistry. 2012; 123(2):217-225. Available from: https://doi.org/10.1111/j.1471-4159.2012.07891.x
https://doi.org/10.1111/j.1471-4159.2012.07891.x
PMid:22845688
21. Mehta A, Mahale R, Buddaraju K, et al. Efficacy of Neuroprotective Drugs in Acute Ischemic Stroke: Is It Helpful? JNRP. 2019; 10(4):576-581. Available from: https://doi.org/10.1055/s-0039-170079
https://doi.org/10.1055/s-0039-1700790
PMid:31831974 PMCid:PMC6906097
22. Lee MC, Jin CY, Kim HS, et al. Stem cell dynamics in an experimental model of stroke. Chonnam medical journal. 2011; 47(2):90-98. Available from: https://doi.org/10.4068/cmj.2011.47.2.90
https://doi.org/10.4068/cmj.2011.47.2.90
PMid:22111067 PMCid:PMC3214868
23. Hu Y, Chen W, Wu L, Jiang L, Qin H, Tang, N. Hypoxic preconditioning improves the survival and neural effects of transplanted mesenchymal stem cells via CXCL12/CXCR4 signalling in a rat model of cerebral infarction. Cell Biochem Funct. 2019; 37:504-515. Available from: https://doi.org/10.1002/cbf.3423
https://doi.org/10.1002/cbf.3423
PMid:31368195
24. Son JW, Park J, Kim YE, Ha J, Park D.W, Chang MS. Glia-like cells from late-passage human MSCs protect against ischemic stroke through IGFBP-4. Mol Neurobiol. 2019; 56:7617-7630. Available from: https://doi.org/10.1007/s12035-019-1629-8
https://doi.org/10.1007/s12035-019-1629-8
PMid:31081524
25. Gutierrez-Fernandez M, Otero-Ortega L, Ramos-Cejudo J, Rodriguez-Frutos B, Fuentes B, Diez-Tejedor E. Adipose tissue-derived mesenchymal stem cells as a strategy to improve recovery after stroke. Expert Opin Biol Ther. 2015; 15:873-881.
https://doi.org/10.1517/14712598.2015.1040386
PMid:25959243
26. Zhang Y, Liu J, Su M, Wang X, Xie C. Exosomal microRNA-22-3p alleviates cerebral ischemic injury by modulating KDM6B/BMP2/BMF axis. Stem Cell Res Ther. 2021; 12:111.
https://doi.org/10.1186/s13287-020-02091-x
PMid:33546766 PMCid:PMC7863295
27. Zhang L, Wang LM, Chen WW, Ma Z, Han X, Liu CM, et al. Neural differentiation of human Wharton’s jelly-derived mesenchymal stem cells improves the recovery of neurological function after transplantation in ischemic stroke rats. Neural Regen Res. 2017; 12(7):1103-1110. Available from: https://doi.org/10.4103/1673-5374.211189
https://doi.org/10.4103/1673-5374.211189
PMid:28852392 PMCid:PMC5558489
28. Wu KJ, Yu SJ, Chiang CW, Lee YW, Yen BL, Hsu CS, et al. Wharton’ jelly mesenchymal stromal cell therapy for ischemic brain injury. Brain Circ. 2018; 4(3):124-127. Available from: https://doi.org/10.4103/bc.bc_16_18
https://doi.org/10.4103/bc.bc_16_18
PMid:30450419 PMCid:PMC6187942
29. Russo E, Lee JY, Nguyen H, Corrao S, Anzalone R, La Rocca G, et al. Energy Metabolism Analysis of Three Different Mesenchymal Stem Cell Populations of Umbilical Cord Under Normal and Pathologic Conditions. Stem Cell Rev Rep. 2020; 16(3):585-595. Available from: https://doi.org/10.1007/s12015-020-09967-8
https://doi.org/10.1007/s12015-020-09967-8
PMid:32185666 PMCid:PMC7253397
30. Fu YS, Yeh CC, Chu PM, Chang WH, Lin MA, Lin YY. Xenograft of Human Umbilical Mesenchymal Stem Cells Promotes Recovery from Chronic Ischemic Stroke in Rats. Int J Mol Sci. 2022; 23(6):3149. Available from: https://doi.org/10.3390/ijms23063149
https://doi.org/10.3390/ijms23063149
PMid:35328574 PMCid:PMC8953545
31. Ribeiro CA, Fraga JS, Grãos M, Neves NM, Reis RL, et al. The secretome of stem cells isolated from the adipose tissue and Wharton jelly acts differently on central nervous system -derived cell populations. Stem Cell Res Ther. 2012; 3:18. Available from: https://doi.org/10.1186/scrt109
https://doi.org/10.1186/scrt109
PMid:22551705 PMCid:PMC3392765

Konovalov S, Moroz V, Deryabina O, Klymenko P, Tochylovsky A, Kordium V. The effect of mesenchymal stromal cells of various origins on morphology of hippocampal CA1 area of rats with acute cerebral ischemia. Cell Organ Transpl. 2022; 10(2):in press. doi:10.22494/cot.v10i2.144

Creative Commons License
Is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.